Kristen Lund
Payments from drug & device makers
Across 243 payments — averaging $20.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$628
- Lilly USA, LLC$437
- Amgen$419
- AbbVie$350
- Abiomed$302
- Pfizer$298
- plus $3K from 36 others
What the payments were for
- Food & beverage$5,00198%
- Education$842%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 35 | $628 |
| Lilly USA, LLC | 24 | $437 |
| Amgen | 22 | $419 |
| AbbVie | 21 | $350 |
| Abiomed | 5 | $302 |
| Pfizer | 16 | $298 |
| Otsuka America Pharmaceutical, Inc. | 14 | $273 |
| Astellas Pharma US Inc | 6 | $262 |
| AstraZeneca | 9 | $238 |
| GSK | 10 | $183 |
| Axsome Therapeutics, Inc. | 8 | $159 |
| Boehringer Ingelheim | 6 | $136 |
| Dexcom, Inc. | 6 | $127 |
| Exact Sciences | 6 | $113 |
| Cleerly, Inc. | 1 | $112 |
| Idorsia Pharmaceuticals US Inc | 8 | $110 |
| Viiv Healthcare Company | 5 | $97 |
| Abbott | 4 | $91 |
| Indivior Inc. | 3 | $64 |
| Sanofi-aventis U.S. LLC | 3 | $60 |
| Ardelyx, Inc. | 2 | $49 |
| Seqirus USA Inc | 3 | $49 |
| Johnson & Johnson | 3 | $47 |
| Lundbeck LLC | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Hologic Sales And Service, LLC | 1 | $34 |
| Noven Therapeutics, LLC | 2 | $31 |
| Verity Pharmaceuticals Inc. | 1 | $30 |
| Corium, LLC | 1 | $29 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Heartflow, Inc. | 1 | $26 |
| Boston Scientific | 1 | $26 |
| Inari Medical, Inc. | 1 | $24 |
| Stryker | 1 | $22 |
| Bayer | 1 | $19 |
| BD | 1 | $19 |
| Philips North America LLC | 1 | $18 |
| Merck | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$147
- Veozah$125
- Ozempic$124
- FARXIGA$119
- Cleerly Ischemia$112
- Cleerly Labs$112
- MOUNJARO$109
How this compares
$5,085 in reported general payments places this provider in the 85th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Eszopiclone | 33 | $671 |
| Clonazepam | 66 | $508 |
| Rosuvastatin Calcium | 31 | $386 |
| Zaleplon | 11 | $310 |
| Tramadol Hcl | 30 | $250 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $246 |
| Alprazolam | 33 | $208 |
| Zolpidem Tartrate | 30 | $187 |
| Losartan Potassium | 12 | $145 |
| Pantoprazole Sodium | 12 | $119 |
| Methylprednisolone | 14 | $95 |
| Duloxetine Hcl | 11 | $89 |
| Azithromycin | 26 | $77 |
| Lorazepam | 38 | $75 |
| Amlodipine Besylate | 17 | $71 |
Paid to pharmacies, not to this prescriber.
Other medical in Allen
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Courtney AldridgeSan Antonio$129K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
- Janine ShinnDallas$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.